CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in CLYM — Climb Bio, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in CLYM

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,364,427

+$1,213,378 QoQ

Shares Held

104,634

+374.5% QoQ

Ownership

0.182%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#47

of 108 holders

Holding Since

Sep 2021

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $7,346,663,053 across 299 Biotechnology names. CLYM ranks #209 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	2,041,282	$1,013,966,007
2	REGN	Regeneron Pharmaceuticals, Inc.	846,306	$527,705,642
3	RVMD	Revolution Medicines, Inc.	1,917,025	$359,020,441
4	MRNA	Moderna, Inc.	4,838,884	$338,867,045
5	ALNY	Alnylam Pharmaceuticals, Inc.	755,377	$227,391,137
6	INCY	Incyte Corp	1,692,439	$191,854,884
7	RPRX	Royalty Pharma plc	3,083,528	$172,893,414
8	CYTK	Cytokinetics Inc	1,565,781	$133,388,883

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,364,427	104,634	+374.5%	Shares	Sole	2026-08-14
2026-03-31	$151,049	22,051	-68.5%	Shares	Sole	2026-05-15
2025-03-31	$85,513	70,093	0.0%	Shares	Sole	2025-09-15
2024-12-31	$126,167	70,093	0.0%	Shares	Sole	2025-02-06
2024-09-30	$356,773	70,093	+309.2%	Shares	Sole	2024-11-12
2024-06-30	$121,780	17,128	+7.0%	Shares	Sole	2024-08-12
2022-03-31	$134,248	16,001	-7.1%	Shares	Sole	2022-05-13
2021-12-31	$180,163	17,224	0.0%	Shares	Sole	2022-02-11
2021-09-30	$309,687	17,224	—	Shares	Sole	2021-11-16
No filing history on record for this holder in this stock.